Información de Teva Pharmaceutical Industries Ltd, dividendo de Teva Pharmaceutical Industries Ltd, actividades de los accionistas y más

Más Datos de Teva Pharmaceutical Industries Ltd Compañía

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Información de Teva Pharmaceutical Industries Ltd



Símbolo de cotizaciónTEVA

Nombre de la empresaTeva Pharmaceutical Industries Ltd

Fecha de salida a bolsaJan 01, 1951

Director ejecutivoMr. Richard D. Francis

Número de empleados33892

Tipo de seguridadOrdinary Share

Fin del año fiscalJan 01

Dirección124 Dvora Hanevi'a St.

CiudadTEL AVIV-YAFO

Bolsa de valoresTel Aviv Stock Exchange

PaísIsrael

Código postal6944020

Teléfono97239148213

Sitio Webhttps://www.tevapharm.com/

Símbolo de cotizaciónTEVA

Fecha de salida a bolsaJan 01, 1951

Director ejecutivoMr. Richard D. Francis

Ejecutivos de Teva Pharmaceutical Industries Ltd



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

13.03K

+9.34%

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

13.03K

+9.34%

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Generic products

2.41B

57.73%

AUSTEDO

498.00M

11.93%

Anda

365.00M

8.74%

Other

247.00M

5.91%

AJOVY

154.00M

3.69%

Otro

501.00M

12.00%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

2.15B

51.51%

Europe

1.30B

31.06%

International Markets

495.00M

11.85%

Other

232.00M

5.56%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Generic products

2.41B

57.73%

AUSTEDO

498.00M

11.93%

Anda

365.00M

8.74%

Other

247.00M

5.91%

AJOVY

154.00M

3.69%

Otro

501.00M

12.00%

Estadísticas de accionistas

Actualizado: mar., 4 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

Menora Mivtachim Insurance Ltd.

5.00%

Fidelity Management & Research Company LLC

4.41%

Phoenix Investment and Finances Ltd

3.60%

Ion Asset Management Israel Ltd

3.34%

Harel Insurance Investments and Financial Services Ltd

3.29%

Otro

80.35%

Accionistas

Proporción

Menora Mivtachim Insurance Ltd.

5.00%

Fidelity Management & Research Company LLC

4.41%

Phoenix Investment and Finances Ltd

3.60%

Ion Asset Management Israel Ltd

3.34%

Harel Insurance Investments and Financial Services Ltd

3.29%

Otro

80.35%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

25.80%

Hedge Fund

13.29%

Investment Advisor/Hedge Fund

11.28%

Insurance Company

7.85%

Research Firm

2.46%

Pension Fund

1.90%

Family Office

1.42%

Bank and Trust

0.90%

Sovereign Wealth Fund

0.24%

Otro

34.85%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Menora Mivtachim Insurance Ltd.

57.40M

5%

+18.90M

+49.10%

Jul 16, 2025

Fidelity Management & Research Company LLC

50.63M

4.41%

-24.67M

-32.76%

Jun 30, 2025

Phoenix Investment and Finances Ltd

37.76M

3.29%

+10.30M

+37.49%

Jun 30, 2025

Ion Asset Management Israel Ltd

38.35M

3.34%

-685.63K

-1.76%

Jun 30, 2025

Harel Insurance Investments and Financial Services Ltd

33.39M

2.91%

+11.33M

+51.39%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

33.89M

2.95%

+833.03K

+2.52%

Jun 30, 2025

Migdal Insurance and Financial Holdings Ltd

28.69M

2.5%

+2.35M

+8.92%

Jun 30, 2025

Clal Insurance Enterprises Holdings Ltd.

32.36M

2.82%

-5.43M

-14.37%

Jun 30, 2025

Lingotto Investment Management LLP

28.16M

2.45%

+302.98K

+1.09%

Jun 30, 2025

Rubric Capital Management LP

26.00M

2.27%

+450.00K

+1.76%

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

VanEck Israel ETF

7.07%

iShares MSCI Israel ETF

6.66%

ARK Israel Innovative Technology ETF

1.9%

VanEck Pharmaceutical ETF

1.73%

WealthTrust DBS Long Term Growth ETF

1.36%

WisdomTree International Multifactor Fund

0.59%

iShares Health Innovation Active ETF

0.5%

iShares MSCI Intl Value Factor ETF

0.41%

iShares MSCI EAFE Value ETF

0.14%

DFA Dimensional Internatl High Profitability ETF

0.12%

VanEck Israel ETF

Proporción7.07%

iShares MSCI Israel ETF

Proporción6.66%

ARK Israel Innovative Technology ETF

Proporción1.9%

VanEck Pharmaceutical ETF

Proporción1.73%

WealthTrust DBS Long Term Growth ETF

Proporción1.36%

WisdomTree International Multifactor Fund

Proporción0.59%

iShares Health Innovation Active ETF

Proporción0.5%

iShares MSCI Intl Value Factor ETF

Proporción0.41%

iShares MSCI EAFE Value ETF

Proporción0.14%

DFA Dimensional Internatl High Profitability ETF

Proporción0.12%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos